After evaluating the incidence of somatic mutations of 23 m6A regulators in AML, we concluded that the alteration frequency was only 1.04% among 193 samples with two missense mutations identified in METTL3 and RBMX (Figure 1C). This evidence concerns the gene RBMX and acute myeloid leukemia.